Nectar Lifesciences Revenue

In the fiscal year ending March 31, 2025, Nectar Lifesciences had annual revenue of 16.70B INR, down -0.87%. Nectar Lifesciences had revenue of 4.29B in the quarter ending March 31, 2025, a decrease of -2.59%.

Revenue

16.70B

Revenue Growth

-0.87%

P/S Ratio

0.24

Revenue / Employee

9.90M

Employees

1,686

Market Cap

4.02B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	16.70B	-145.97M	-0.87%
Mar 31, 2024	16.85B	1.61B	10.56%
Mar 31, 2023	15.24B	-1.45B	-8.70%
Mar 31, 2022	16.69B	1.26B	8.13%
Mar 31, 2021	15.43B	-8.23B	-34.78%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sun Pharmaceutical Industries	525.78B
Divi's Laboratories	93.60B
Cipla	272.67B
Mankind Pharma	122.07B
Apollo Hospitals Enterprise	217.94B
Zydus Lifesciences	232.42B
Aurobindo Pharma	317.24B
Glenmark Pharmaceuticals	134.35B

Revenue Rankings

Nectar Lifesciences News

7 days ago - Nectar Lifesciences shares fall 15% as it announces sale of core business division - Business Upturn
4 months ago - Nectar Lifesciences shares hit 5% lower circuit, down 10% in two days amid EU regulatory concerns - Business Upturn
5 months ago - Nectar Lifesciences shares surge nearly 5% as Q3 profit jumps 400% YoY - Business Upturn
5 months ago - Nectar Lifesciences Q3 FY25 results: Profit after tax rises nearly 400% YoY to Rs 7.84 crore - Business Upturn

More News